Yongjun Sui1, Eun Mi Lee, Yichuan Wang, Alison Hogg, Blake Frey, David Venzon, Ranajit Pal, Jay A Berzofsky. 1. *Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; †Advanced BioScience Laboratories, Inc., Rockville, MD; and ‡Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVE: Few studies have examined the eclipse time of simian immunodeficiency virus/HIV infection through the anal route. We aimed to measure the eclipse time after SIVmac251 intrarectal inoculation, and to investigate the factor(s) associated with early dissemination. DESIGN: Forty macaques were intrarectally challenged with SIVmac251 3 times at 2-week intervals. METHODS: Plasma viral RNA was monitored at 4, 7, 11, 14, 21, and 28 days after infection. Rectal/vaginal tissues were obtained and tissue viral loads (VLs) were measured at day 14 postinfection. RESULTS: Of 40 macaques 26 (65%) had first detectable viral RNAs in the plasma at day 7 after the challenge that led to productive infection. Strikingly, 6 animals (15%) had detectable viral RNA in the plasma as early as at day 4. The Ki67 viral target CD4 T cells in the colorectal tissues were significantly higher in the early or middle-transmitter groups than those in the late-transmitter group. The rectal VL did not correlate with plasma VL at 14-day postinoculation, but did positively correlate with plasma VLs at days 21 and 28 postinfection. CONCLUSIONS: The median eclipse time after intrarectal challenge was 7 days, with a few early transmitters at 4 days. More rapid viral dissemination was associated with a high frequency of colorectal Ki67CCR5CD4T cells, which fuel the local viral replication. Furthermore, local viral replication in the colorectal tissue during the early stage might affect the plasma VL in a delayed manner. Therefore, to reduce/limit these target cells at the portal of viral entry is essential.
OBJECTIVE: Few studies have examined the eclipse time of simian immunodeficiency virus/HIV infection through the anal route. We aimed to measure the eclipse time after SIVmac251 intrarectal inoculation, and to investigate the factor(s) associated with early dissemination. DESIGN: Forty macaques were intrarectally challenged with SIVmac251 3 times at 2-week intervals. METHODS: Plasma viral RNA was monitored at 4, 7, 11, 14, 21, and 28 days after infection. Rectal/vaginal tissues were obtained and tissue viral loads (VLs) were measured at day 14 postinfection. RESULTS: Of 40 macaques 26 (65%) had first detectable viral RNAs in the plasma at day 7 after the challenge that led to productive infection. Strikingly, 6 animals (15%) had detectable viral RNA in the plasma as early as at day 4. The Ki67 viral target CD4 T cells in the colorectal tissues were significantly higher in the early or middle-transmitter groups than those in the late-transmitter group. The rectal VL did not correlate with plasma VL at 14-day postinoculation, but did positively correlate with plasma VLs at days 21 and 28 postinfection. CONCLUSIONS: The median eclipse time after intrarectal challenge was 7 days, with a few early transmitters at 4 days. More rapid viral dissemination was associated with a high frequency of colorectal Ki67CCR5CD4T cells, which fuel the local viral replication. Furthermore, local viral replication in the colorectal tissue during the early stage might affect the plasma VL in a delayed manner. Therefore, to reduce/limit these target cells at the portal of viral entry is essential.
Authors: Christopher J Miller; Qingsheng Li; Kristina Abel; Eun-Young Kim; Zhong-Min Ma; Stephen Wietgrefe; Lisa La Franco-Scheuch; Lara Compton; Lijie Duan; Marta Dykhuizen Shore; Mary Zupancic; Marc Busch; John Carlis; Steven Wolinsky; Steven Wolinksy; Ashley T Haase Journal: J Virol Date: 2005-07 Impact factor: 5.103
Authors: Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer Journal: PLoS One Date: 2012-01-26 Impact factor: 3.240
Authors: Yongjun Sui; Susan Gagnon; Amiran Dzutsev; Qing Zhu; Huifeng Yu; Alison Hogg; Yichuan Wang; Zheng Xia; Igor M Belyakov; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Jay A Berzofsky Journal: Vaccine Date: 2011-10-29 Impact factor: 3.641
Authors: Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker Journal: J Immunol Date: 2005-11-01 Impact factor: 5.422
Authors: J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels Journal: J Infect Dis Date: 1999-04 Impact factor: 5.226
Authors: James B Whitney; Alison L Hill; Srisowmya Sanisetty; Pablo Penaloza-MacMaster; Jinyan Liu; Mayuri Shetty; Lily Parenteau; Crystal Cabral; Jennifer Shields; Stephen Blackmore; Jeffrey Y Smith; Amanda L Brinkman; Lauren E Peter; Sheeba I Mathew; Kaitlin M Smith; Erica N Borducchi; Daniel I S Rosenbloom; Mark G Lewis; Jillian Hattersley; Bei Li; Joseph Hesselgesser; Romas Geleziunas; Merlin L Robb; Jerome H Kim; Nelson L Michael; Dan H Barouch Journal: Nature Date: 2014-07-20 Impact factor: 49.962
Authors: Yongjun Sui; George K Lewis; Yichuan Wang; Kurt Berckmueller; Blake Frey; Amiran Dzutsev; Diego Vargas-Inchaustegui; Venkatramanan Mohanram; Thomas Musich; Xiaoying Shen; Anthony DeVico; Timothy Fouts; David Venzon; James Kirk; Robert C Waters; James Talton; Dennis Klinman; John Clements; Georgia D Tomaras; Genoveffa Franchini; Marjorie Robert-Guroff; Giorgio Trinchieri; Robert C Gallo; Jay A Berzofsky Journal: J Clin Invest Date: 2019-02-18 Impact factor: 14.808
Authors: Kara Jensen; Myra Grace Dela Pena-Ponce; Michael Piatak; Rebecca Shoemaker; Kelli Oswald; William R Jacobs; Glenn Fennelly; Carissa Lucero; Katie R Mollan; Michael G Hudgens; Angela Amedee; Pamela A Kozlowski; Jacob D Estes; Jeffrey D Lifson; Koen K A Van Rompay; Michelle Larsen; Kristina De Paris Journal: Clin Vaccine Immunol Date: 2017-01-05
Authors: Adam J Ericsen; Michael Lauck; Mariel S Mohns; Sarah R DiNapoli; James P Mutschler; Justin M Greene; Jason T Weinfurter; Gabrielle Lehrer-Brey; Trent M Prall; Samantha M Gieger; Connor R Buechler; Kristin A Crosno; Eric J Peterson; Matthew R Reynolds; Roger W Wiseman; Benjamin J Burwitz; Jacob D Estes; Jonah B Sacha; Thomas C Friedrich; Jason M Brenchley; David H O'Connor Journal: PLoS Pathog Date: 2016-12-07 Impact factor: 6.823